IUPAC/Chemical Name
N-((5-(Dimethylamino)-1-naphthyl)sulphonyl)glycine
InChi Key
QHFXORCWAQTTGH-UHFFFAOYSA-N
InChi Code
InChI=1S/C14H16N2O4S/c1-16(2)12-7-3-6-11-10(12)5-4-8-13(11)21(19,20)15-9-14(17)18/h3-8,15H,9H2,1-2H3,(H,17,18)
SMILES Code
O=C(O)CNS(=O)(C1=C2C=CC=C(N(C)C)C2=CC=C1)=O
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
Preparing Stock Solutions
The following data is based on the
product
molecular weight
308.35
Batch specific molecular weights may vary
from batch to batch
due to the degree of hydration, which will
affect the solvent
volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass |
1 mg |
5 mg |
10 mg |
| 1 mM |
1.15 mL |
5.76 mL |
11.51 mL |
| 5 mM |
0.23 mL |
1.15 mL |
2.3 mL |
| 10 mM |
0.12 mL |
0.58 mL |
1.15 mL |
| 50 mM |
0.02 mL |
0.12 mL |
0.23 mL |
1: Bertozo LC, Zeraik ML, Ximenes VF. Dansylglycine, a fluorescent probe for specific determination of halogenating activity of myeloperoxidase and eosinophil peroxidase. Anal Biochem. 2017 Sep 1;532:29-37. doi: 10.1016/j.ab.2017.05.029. Epub 2017 Jun 3. PMID: 28587811.
2: Graciani FS, Ximenes VF. Investigation of human albumin-induced circular dichroism in dansylglycine. PLoS One. 2013 Oct 16;8(10):e76849. doi: 10.1371/journal.pone.0076849. PMID: 24146932; PMCID: PMC3797758.
3: Bramhall J. Use of the fluorescent weak acid dansylglycine to measure transmembrane proton concentration gradients. Biochemistry. 1986 Jul 1;25(13):3958-62. doi: 10.1021/bi00361a033. PMID: 3755615.
4: De Carvalho Bertozo L, Morgon NH, De Souza AR, Ximenes VF. Taurine Bromamine: Reactivity of an Endogenous and Exogenous Anti-Inflammatory and Antimicrobial Amino Acid Derivative. Biomolecules. 2016 Apr 21;6(2):23. doi: 10.3390/biom6020023. PMID: 27110829; PMCID: PMC4919918.
5: Muller N, Lapicque F, Drelon E, Netter P. Binding sites of fluorescent probes on human serum albumin. J Pharm Pharmacol. 1994 Apr;46(4):300-4. doi: 10.1111/j.2042-7158.1994.tb03798.x. PMID: 7519671.
6: Lacaille-Dubois, Franck U, Wagner H. Search for potential angiotensin converting enzyme (ACE)-inhibitors from plants. Phytomedicine. 2001 Jan;8(1):47-52. doi: 10.1078/0944-7113-00003. PMID: 11292239.
7: Robertz GM, Dengler HJ. Endogenous ligand(s) decrease drug--protein binding in uremic sera: a fluorescence probe study. Klin Wochenschr. 1983 Jul 1;61(13):649-53. doi: 10.1007/BF01487581. PMID: 6688447.
8: Marin M, Lhiaubet-Vallet V, Miranda MA. Site-dependent photo-fries rearrangement within serum albumins. J Phys Chem B. 2011 Mar 31;115(12):2910-5. doi: 10.1021/jp2009463. Epub 2011 Mar 8. PMID: 21384817.
9: Dömötör O, Hartinger CG, Bytzek AK, Kiss T, Keppler BK, Enyedy EA. Characterization of the binding sites of the anticancer ruthenium(III) complexes KP1019 and KP1339 on human serum albumin via competition studies. J Biol Inorg Chem. 2013 Jan;18(1):9-17. doi: 10.1007/s00775-012-0944-6. Epub 2012 Oct 18. PMID: 23076343.
10: Ximenes VF, Morgon NH, de Souza AR. Hypobromous acid, a powerful endogenous electrophile: Experimental and theoretical studies. J Inorg Biochem. 2015 May;146:61-8. doi: 10.1016/j.jinorgbio.2015.02.014. Epub 2015 Mar 2. PMID: 25771434.
